- Home
- TRAW vs GURE Comparison
TRAW vs GURE Comparison
Compare TRAW & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAW
- GURE
- Stock Information
- Founded
- TRAW 1998
- GURE 2006
- Country
- TRAW United States
- GURE China
- Employees
- TRAW N/A
- GURE N/A
- Industry
- TRAW
- GURE Major Chemicals
- Sector
- TRAW
- GURE Industrials
- Exchange
- TRAW NYSE
- GURE Nasdaq
- Market Cap
- TRAW 8.6M
- GURE 8.5M
- IPO Year
- TRAW 2013
- GURE 1992
- Fundamental
- Price
- TRAW $1.48
- GURE $0.73
- Analyst Decision
- TRAW
- GURE
- Analyst Count
- TRAW 0
- GURE 0
- Target Price
- TRAW N/A
- GURE N/A
- AVG Volume (30 Days)
- TRAW 3.4M
- GURE 2.0M
- Earning Date
- TRAW 08-14-2025
- GURE 05-13-2025
- Dividend Yield
- TRAW N/A
- GURE N/A
- EPS Growth
- TRAW N/A
- GURE N/A
- EPS
- TRAW N/A
- GURE N/A
- Revenue
- TRAW $227,000.00
- GURE $7,958,395.00
- Revenue This Year
- TRAW $3.81
- GURE N/A
- Revenue Next Year
- TRAW $30.43
- GURE N/A
- P/E Ratio
- TRAW N/A
- GURE N/A
- Revenue Growth
- TRAW 0.44
- GURE N/A
- 52 Week Low
- TRAW $0.97
- GURE $0.50
- 52 Week High
- TRAW $19.44
- GURE $1.65
- Technical
- Relative Strength Index (RSI)
- TRAW 43.63
- GURE 54.94
- Support Level
- TRAW $1.37
- GURE $0.65
- Resistance Level
- TRAW $1.49
- GURE $0.99
- Average True Range (ATR)
- TRAW 0.11
- GURE 0.08
- MACD
- TRAW -0.03
- GURE 0.00
- Stochastic Oscillator
- TRAW 12.07
- GURE 40.07
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.